Figure INF-6. HCV antibody prevalence among injecting drug users — studies with national and subnational coverage [see all figures in this series...]

Part (ii) Young injecting drug users (under age 25), 2007 to 2008

Notes:

Squares are samples with national coverage; triangles are samples with subnational (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Data for Portugal, Cyprus, Malta, Romania, Slovenia and Slovakia are limited to prevalence among IDUs in treatment and may not be representative of prevalence among IDUs who are not in treatment.

Part of data from Portugal and Hungary include non-IDUs and therefore may underestimate prevalence among IDUs (estimated proportion of non-IDUs in the samples not known).

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of subnational data.

Related links:

Statistical bulletin 2009: Figure INF-6 part (ii)

For primary sources, study details and data before 2007, see Table INF-112 and Table INF-0.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

Reitox national focal points